DocDollars

Coherus Oncology, Inc.

CA · United States · Reporting entity ID 100000506819

Total reported 2019–2025
$15.3M
#386 of 2,960 reporting companies — 0% of all reported industry payments
$2.66M in general payments across 14,849 records, plus $12.6M in research funding across 2,380 records.

How it breaks down

General payments $2,664,291
Research funding $12,599,814

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Coherus Oncology, Inc. reported $15.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #386 of 2,960 reporting companies. 83% of that was research funding and 17% general payments such as consulting, speaking, food and travel. 14,849 general payment records and 2,380 research records were filed.

Common questions about Coherus Oncology, Inc.

How much has Coherus Oncology, Inc. paid US doctors?

Coherus Oncology, Inc. reported $15,264,105 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,664,291 in general payments, $12,599,814 in research funding.

How does Coherus Oncology, Inc. rank among drug and device companies?

It ranks #386 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Coherus Oncology, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.